Response

Chest. 2018 Aug;154(2):460-461. doi: 10.1016/j.chest.2018.04.042.

Authors

Mohammad Hassan Murad¹, Susan R Kahn²

Affiliations

¹ Division of Preventive Medicine, Mayo Clinic, Rochester, MN. Electronic address: murad.mohammed@mayo.edu.
² Center for Clinical Epidemiology, Lady Davis Institute, Montreal, Canada; Department of Medicine, McGill University, Montreal, Canada.

PMID: 30080513
DOI: 10.1016/j.chest.2018.04.042

No abstract available

Publication types

Letter
Comment

MeSH terms

Fibrinolytic Agents*
Humans
Thorax
Thrombosis*
United States

Substances

Fibrinolytic Agents